• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Anti-Depressants
    46 Drugs classified under this therapeutic system

    All the Therapeutic System Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    full basket chart

    TCA. Clomipramine HCl 25 mg, 75 mg.
    TABS: 30 x 25 mg. 1 tab. dly. in div.
    doses. Severe cases: 75-100 mg dly. in
    div. doses.
    Depress. varying origin. Child and adolesc.
    (0-17 yrs): Not recommend. Obsess.
    compuls. disords: Not for child under 5 yrs.
    C/I: Not to be used with or within 14
    days of tmt. with MAO inhibit., liver
    damage, card. or circulat. failure,
    hypotens. tendency, glaucoma, urine

    partial basket chart

    Atypical Antipsychotic. Aripiprazole 5, 10, 15, 30 mg.
    TABS: 28 x 5 mg, 10 mg, 15 mg, 30
    Take whole w/out meals. Schizophren:
    Adult >18 yrs: 10-15 mg dly. Maint. 15
    mg dly, max. 30 mg dly. Adolescents
    (15 yrs and older): recommend. dose
    10 mg dly. Max. dly dose: 30 mg.
    Mania: Adult >18 yrs: 15 mg daily, incr.
    if necess. to 30 mg dly. Not to exceed
    recomm. dose. Irritability
    Assoc. with Autistic Dis. (6-17 yrs):
    initiate at 2.5 mg/d, dose range 5 – 15
    mg dly. See lit.
    Tmt. of schizophrenia, tmt. of mod.- severe
    manic epis. in Bipolar I disord., prevent. of
    a new manic epis. in pts who experienced
    predomin. manic epis. whose manic
    epis. respond. to aripiprazole tmt. Use as
    an adjunct. ther. to antidepress. for tmt. of
    major depress. dis. (MDD). Efficacy was
    establ. in two 6-week trials in adults with
    MDD who had an inadeq. resp. to
    antidepr. ther. during the curr. epis. Tmt. of
    irritability assoc. with autistic dis. Efficacy
    was establ. in two 8-week trials in ped. pts
    (aged 6 - 17 yrs) with irritab. assoc. with
    autistic dis. (incl. sympt. of aggress.
    towards others, delib. self-inj., temper
    tantrums, quickly chang. moods).
    C/I: Hypersens.

    Axiban Sublingual Drops IMC-Medical Grade Cannabis Oil
    not in the basket chart
    Multiple ingredients
    Axiban Sublingual Drops IMC-Medical Grade Cannabis Oil

    Cannabinoids. THC 0.3, 0.9, 1.5, 3, 4.5, 6 mg/drop, CBD 0.6, 0.9, 1.2, 3, 4.5, 6 mg/drop.
    *This product requires a license for medical cannabis.
    BOTTLE. (sublingual drop.): 10gr (330 drops). Dosage should be adjust. individual.
    The Israel MOH has outlined in Guidance 106 the 12 indicat. for which med. cannabis is indicated. Accord. to this guidance, the 11 indicat. for this product are:
    Chemother-induc. nausea and vomit. (CINV)/ chemother induc. pain.
    Metastat. cancer pain.
    Neuropath. pain.
    Spastic. of MS.
    Pain in Parkinson's dis.
    Cachexia in AIDS.
    Tourette's syndr.
    Recalcitrant epilep. in adult. (Note: Accord. to Guidance 106, med. cannab. is also indic. for recalcitrant epilep. in ped. pts. but this is not an indicat. for this product)
    Palliative care for termin. ill pts.
    Post- traum. stress disord.
    In general, the use of med. cannabis is indicated in pts. who have adequate. tried and failed convent. ther.
    Please refer to Guidance 106 for details.
    In addition, for an individ. pt. with a clinical. signific. med. condit. that cannot be adequate. managed by convent. ther. and which is not includ. as one of the 12 approved indicat. (eg autism, fibromyalgia), the physician can appeal to the MOH Committee for Med. Cannabis to ask for approval on an individ. exception. basis.
    C/I: Prior, current/ family history (1st degr. relative) of psychos. or schizophr. or schizoaffective disord., a hist. of addict. or substance abuse (include. cannabis use disord.or addict. to alcohol), use in preg.or lact., use in pts. <18 yrs. old, bipol.disord., hypersens. to cannabis, coconut oil, palm kernel oil.
    In pts. with hepat. cancer, it is recommend. not to use med. cannab. that contains THC.
    See lit.

    partial basket chart

    TCA. Mianserin HCl 30 mg.
    TABS: 20. 30-90 mg dly.
    C/I: Mania.

    not in the basket chart

    Antidepressants. Vortioxetine (as Hydrobromide) 5, 10, 15, 20 mg.
    F.C. TABS.: 7, 14, 28. Start. and recom. dose of 10 mg×1/d adult. <65 yrs. of age. Depend. on individ. response, the dose may be incr.to a max. of 20 mg×1/d or decr. to a minim. of 5 mg ×1/d . After the depress. sympt. resolve, tmt. for at least 6 mths. is recomm. for consolidation of the antidepressive response. Elderly: initial 5 mg dly, caution when treat. Pt. with higher than 10 mg doses. Pediatrics: Not recommend. in child. Cyt P450
    inhibitors, Cyt P450 inducers: a lower dose of vortioxetine may be considered. Treat. discont. w/o the need for grad. reduc. See lit.
    Tmt. of major depressive episodes in adults.
    C/I: Hypersens.Concom. use with nonselec. MAOIs or selective MAO-A inhib.

    not in the basket chart

    SSRI. Escitalopram (as Oxalate) 10, 15, 20 mg.
    F.C. TABS: 28. Single dly dose with/
    without food. Depress: Usual dose: 10
    mg 1 x dly. Depend. on individ.
    response, dose may be incr. to max. of
    20 mg dly. Panic disords: Initial: 5 mg
    for 1st wk. bef. incr. dose to 10 mg dly.
    Depend on individ. response may incr.
    to max. of 20 mg dly. Elderly (> 65 yrs.):
    1/2 initial dose and lower max. dose.
    See lit.
    Depress., panic disords., gen. anxiety
    disord. (GAD), social anxiety disord. (SAD).
    C/I: Serotonin syndr., child under 18 yrs.,
    lact. See lit.

    Other therapeutic systems under Central Nervous System